Search

To improve the Reemployment Services and Eligibility Assessments (RESEA) program’s success in helping Unemployment Insurance claimants return to work more quickly, Congress introduced requirements that RESEA programs be supported by evidence of…

Across sub-Saharan Africa, at least 100,000 health facilities lack access to reliable electricity and internet connections. This gap threatens health when clinics can’t keep the lights on for nighttime services or reliably provide patients with oxygen…

Having graduated from EPA’s peer review process, the Abt-designed SWEET tool has been updated to better identify and resolve methane emissions.

The Institute of Education Sciences’ What Works Clearinghouse wanted a systematic review of evidence on interventions designed to improve the social, emotional, and behavioral outcomes of students in kindergarten to grade 12. Abt Global and our partners…

Low-income youth and young adults with disabilities (Y&YAD) face a myriad of unique and challenging obstacles to improving their economic well-being, from experiencing homelessness to involvement in the foster care system...

The Immunization Resource Tracking Project strengthened country level data on immunization financing and immunization sustainability. The Abt-led project supported the production of immunization expenditure estimates and the development of policy briefs…

People with a substance use disorder are overrepresented in the justice system, from the arrest phase to incarceration to the risk for recidivism. For example, more than 10 times as many people in prison (58 percent) and sentenced to jail (63 percent)…

The U.S. Department of Agriculture (USDA) faced the challenge of streamlining access to information, tools, and resources for farmers, ranchers, and landowners.

A high number of non-urgent cases that could be addressed by general practice (GP) doctors are presenting unnecessarily at hospital emergency departments (EDs); these are potentially avoidable. Strategies that can save ED health professionals’ time also…

The Centers for Medicare & Medicaid Services created the Cell and Gene Therapy Access Model to be able to negotiate with manufacturers on behalf of states to make high-cost specialty drugs available to beneficiaries and affordable to State Medicaid Agencies.